Literature DB >> 27672085

The Bacterial Second Messenger Cyclic di-GMP Regulates Brucella Pathogenesis and Leads to Altered Host Immune Response.

Mike Khan1, Jerome S Harms2, Fernanda M Marim3, Leah Armon4, Cherisse L Hall5, Yi-Ping Liu5, Menachem Banai6, Sergio C Oliveira3, Gary A Splitter2, Judith A Smith5.   

Abstract

Brucella species are facultative intracellular bacteria that cause brucellosis, a chronic debilitating disease significantly impacting global health and prosperity. Much remains to be learned about how Brucella spp. succeed in sabotaging immune host cells and how Brucella spp. respond to environmental challenges. Multiple types of bacteria employ the prokaryotic second messenger cyclic di-GMP (c-di-GMP) to coordinate responses to shifting environments. To determine the role of c-di-GMP in Brucella physiology and in shaping host-Brucella interactions, we utilized c-di-GMP regulatory enzyme deletion mutants. Our results show that a ΔbpdA phosphodiesterase mutant producing excess c-di-GMP displays marked attenuation in vitro and in vivo during later infections. Although c-di-GMP is known to stimulate the innate sensor STING, surprisingly, the ΔbpdA mutant induced a weaker host immune response than did wild-type Brucella or the low-c-di-GMP guanylate cyclase ΔcgsB mutant. Proteomics analysis revealed that c-di-GMP regulates several processes critical for virulence, including cell wall and biofilm formation, nutrient acquisition, and the type IV secretion system. Finally, ΔbpdA mutants exhibited altered morphology and were hypersensitive to nutrient-limiting conditions. In summary, our results indicate a vital role for c-di-GMP in allowing Brucella to successfully navigate stressful and shifting environments to establish intracellular infection.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27672085      PMCID: PMC5116723          DOI: 10.1128/IAI.00531-16

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Brucellosis as priority public health challenge in South Eastern European countries.

Authors:  Doncho M Donev
Journal:  Croat Med J       Date:  2010-08       Impact factor: 1.351

Review 2.  Brucellosis.

Authors:  Georgios Pappas; Nikolaos Akritidis; Mile Bosilkovski; Epameinondas Tsianos
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

Review 3.  Nucleotide, c-di-GMP, c-di-AMP, cGMP, cAMP, (p)ppGpp signaling in bacteria and implications in pathogenesis.

Authors:  Dimpy Kalia; Gökçe Merey; Shizuka Nakayama; Yue Zheng; Jie Zhou; Yiling Luo; Min Guo; Benjamin T Roembke; Herman O Sintim
Journal:  Chem Soc Rev       Date:  2012-09-28       Impact factor: 54.564

4.  Comparative proteome analysis of Brucella abortus 2308 and its virB type IV secretion system mutant reveals new T4SS-related candidate proteins.

Authors:  Vladimir Paredes-Cervantes; Raúl Flores-Mejía; Martha C Moreno-Lafont; Humberto Lanz-Mendoza; Ángel T Tello-López; Jane Castillo-Vera; Victoria Pando-Robles; Gerardo Hurtado-Sil; Edith González-González; Octavio Rodríguez-Cortés; Adriana Gutiérrez-Hoya; María T Vega-Ramírez; Rubén López-Santiago
Journal:  J Proteomics       Date:  2011-08-19       Impact factor: 4.044

5.  Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway.

Authors:  Lijun Sun; Jiaxi Wu; Fenghe Du; Xiang Chen; Zhijian J Chen
Journal:  Science       Date:  2012-12-20       Impact factor: 47.728

Review 6.  Cyclic di-GMP: the first 25 years of a universal bacterial second messenger.

Authors:  Ute Römling; Michael Y Galperin; Mark Gomelsky
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

7.  Pseudomonas aeruginosa rugose small-colony variants have adaptations that likely promote persistence in the cystic fibrosis lung.

Authors:  Melissa Starkey; Jason H Hickman; Luyan Ma; Niu Zhang; Susan De Long; Aaron Hinz; Sergio Palacios; Colin Manoil; Mary Jo Kirisits; Timothy D Starner; Daniel J Wozniak; Caroline S Harwood; Matthew R Parsek
Journal:  J Bacteriol       Date:  2009-03-27       Impact factor: 3.490

8.  CD8+ T cell exhaustion, suppressed gamma interferon production, and delayed memory response induced by chronic Brucella melitensis infection.

Authors:  Marina Durward-Diioia; Jerome Harms; Mike Khan; Cherisse Hall; Judith A Smith; Gary A Splitter
Journal:  Infect Immun       Date:  2015-09-28       Impact factor: 3.441

9.  Riboswitches in eubacteria sense the second messenger cyclic di-GMP.

Authors:  N Sudarsan; E R Lee; Z Weinberg; R H Moy; J N Kim; K H Link; R R Breaker
Journal:  Science       Date:  2008-07-18       Impact factor: 47.728

10.  Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum.

Authors:  Jean Celli; Chantal de Chastellier; Don-Marc Franchini; Javier Pizarro-Cerda; Edgardo Moreno; Jean-Pierre Gorvel
Journal:  J Exp Med       Date:  2003-08-18       Impact factor: 14.307

View more
  11 in total

1.  The cGAS/STING Pathway Is Important for Dendritic Cell Activation but Is Not Essential to Induce Protective Immunity against Mycobacterium tuberculosis Infection.

Authors:  Fabio V Marinho; Sulayman Benmerzoug; Stephanie Rose; Priscila C Campos; João T Marques; André Báfica; Glen Barber; Bernhard Ryffel; Sergio C Oliveira; Valerie F J Quesniaux
Journal:  J Innate Immun       Date:  2018-05-23       Impact factor: 7.349

2.  Brucella abortus Triggers a cGAS-Independent STING Pathway To Induce Host Protection That Involves Guanylate-Binding Proteins and Inflammasome Activation.

Authors:  Miriam M Costa Franco; Fernanda Marim; Erika S Guimarães; Natan R G Assis; Daiane M Cerqueira; Juliana Alves-Silva; Jerome Harms; Gary Splitter; Judith Smith; Thirumala-Devi Kanneganti; Nina M G P de Queiroz; Delia Gutman; Glen N Barber; Sergio C Oliveira
Journal:  J Immunol       Date:  2017-12-04       Impact factor: 5.422

Review 3.  The Emerging Roles of STING in Bacterial Infections.

Authors:  Fabio V Marinho; Sulayman Benmerzoug; Sergio C Oliveira; Bernhard Ryffel; V F J Quesniaux
Journal:  Trends Microbiol       Date:  2017-06-15       Impact factor: 17.079

4.  Stimulator of Interferon Genes Promotes Host Resistance Against Pseudomonas aeruginosa Keratitis.

Authors:  Kang Chen; Qiang Fu; Siping Liang; Yiting Liu; Wenting Qu; Yongjian Wu; Xinger Wu; Lei Wei; Yi Wang; Yujuan Xiong; Weijia Wang; Minhao Wu
Journal:  Front Immunol       Date:  2018-06-05       Impact factor: 7.561

5.  Genomic analysis of the original Elberg Brucella melitensis Rev.1 vaccine strain reveals insights into virulence attenuation.

Authors:  Mali Salmon-Divon; Adva Yeheskel; David Kornspan
Journal:  Virulence       Date:  2018       Impact factor: 5.882

6.  Brucella Peptide Cross-Reactive Major Histocompatibility Complex Class I Presentation Activates SIINFEKL-Specific T Cell Receptor-Expressing T Cells.

Authors:  Jerome S Harms; Mike Khan; Cherisse Hall; Gary A Splitter; E Jane Homan; Robert D Bremel; Judith A Smith
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

7.  Doxycycline Induces Apoptosis of Brucella Suis S2 Strain-Infected HMC3 Microglial Cells by Activating Calreticulin-Dependent JNK/p53 Signaling Pathway.

Authors:  Zhao Wang; Yanbai Wang; Huan Yang; Jiayu Guo; Zhenhai Wang
Journal:  Front Cell Infect Microbiol       Date:  2021-04-28       Impact factor: 5.293

Review 8.  Uncovering the Hidden Credentials of Brucella Virulence.

Authors:  R Martin Roop; Ian S Barton; Dariel Hopersberger; Daniel W Martin
Journal:  Microbiol Mol Biol Rev       Date:  2021-02-10       Impact factor: 11.056

Review 9.  Proteomics of Brucella.

Authors:  Ansgar Poetsch; María Inés Marchesini
Journal:  Proteomes       Date:  2020-04-22

10.  Brucella suppress STING expression via miR-24 to enhance infection.

Authors:  Mike Khan; Jerome S Harms; Yiping Liu; Jens Eickhoff; Jin Wen Tan; Tony Hu; Fengwei Cai; Erika Guimaraes; Sergio Costa Oliveira; Richard Dahl; Yong Cheng; Delia Gutman; Glen N Barber; Gary A Splitter; Judith A Smith
Journal:  PLoS Pathog       Date:  2020-10-27       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.